logo
AAT Bioquest

Phospholipase A2 group IIA Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
VarespladibIC5012.0 [1]
(3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic AcidIC50470.0 [1]
ManoalideIC503900.0 [1], 93200.0 [2], 1500000.0 [3]
2-(1-Benzyl-5-methoxy-2-methyl-1h-indol-3-yl)acetamideIC50540.0 [1], 840.0 [2], 880.0 [3], 1000.0 [4]
1,2,4-Oxadiazol-5(2H)-one, 3-[[4-(tetradecyloxy)phenyl]methyl]-IC503400.0 [1], 4000.0 [2]
2-(3-(2-Amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yloxy)propanoic acidIC5011.0 [1], 13.0 [2], 170.0 [3]
Me-indoxamIC503.0 [1], 6.0 [2], 180.0 [3]
((3-(2-Amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1H-indol-4-yl)oxy)acetic acidIC5011.0 [1], 19.0 [2], 275.0 [3]
4-(1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-5-yloxy)-butyric acidIC50189.0 [1], 13500.0 [2], 94000.0 [3]
4-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxy)-butyric acidIC50399.0 [1], 610.0 [2], 3660.0 [3]
2-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxymethyl)-benzoic acidIC50147.0 [1], 7500.0 [2], 22500.0 [3]
(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxy)-acetic acidIC5052.0 [1], 150.0 [2], 1400.0 [3]
3-(1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-5-yloxy)-propane-1-sulfonic acidIC5050.0 [1], 5800.0 [2], 135000.0 [3]
4-(1-Benzyl-2-bromo-3-carbamoylmethyl-6-chloro-1H-indol-5-yloxy)-butyric acidIC5020.0 [1], 1300.0 [2], 3200.0 [3]
4-(1-Benzyl-2-bromo-3-carbamoylmethyl-1H-indol-5-yloxy)-butyric acidIC5073.0 [1], 2860.0 [2], 15900.0 [3]
[3-(1-Benzyl-2-bromo-3-carbamoylmethyl-1H-indol-5-yloxy)-propyl]-phosphonic acidIC5033.0 [1], 2200.0 [2], 6200.0 [3]
(1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-4-yloxy)-acetic acidIC5024.0 [1], 130.0 [2], 1800.0 [3]
(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxymethyl)-phosphonic acidIC501290.0 [1], 5550.0 [2], 73500.0 [3]
[3-(1-Biphenyl-2-ylmethyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-propyl]-phosphonic acidIC5022.0 [1], 7600.0 [2], 39000.0 [3]
4-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-butyric acidIC50152.0 [1], 25000.0 [2], 69000.0 [3]
[3-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-propyl-]-phosphonic acidIC5057.0 [1], 27000.0 [2], 67000.0 [3]
Sodium;2-[3-(2-amino-2-oxoethyl)-1-[(3-chlorophenyl)methyl]-2-methylindol-4-yl]oxyacetateIC5020.0 [1], 52.0 [2], 1200.0 [3]
Sodium;2-[3-(2-amino-2-oxoethyl)-2-methyl-1-[(2-phenylphenyl)methyl]indol-4-yl]oxyacetateIC5010.0 [1], 14.0 [2], 4090.0 [3]
Cacospongionolide BIC504300.0 [1], 86700.0 [2]
5-Benzyloxy-DL-tryptophanIC5042100.0 [1]
4-(3,5-Didodecanoyl-2,4,6-trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chromanIC5080.0 [1], 1000.0 [2]
2-[(1-Benzyl-2-methyl-3-oxamoyl-7,8-dihydro-6H-cyclopenta[g]indol-4-yl)oxy]acetic acidIC506.0 [1], 10.0 [2]
4-Methoxy-2-methyl-1-(phenylmethyl)-1H-indole-3-acetamideIC501180.0 [1], 2360.0 [2]
2-(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)-2-oxo-acetamideIC501230.0 [1], 2560.0 [2]
Spla2-X inhibitor 31IC50310.0 [1]
3-{4-[(4-Octadecylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2,4-oxadiazol-5-oneIC505080.0 [1]
3-({4-[(4-Octadecylpiperazin-1-yl)methyl]phenyl}methyl)-4,5-dihydro-1,2,4-oxadiazol-5-oneIC502200.0 [1]
3-({4-[(4-Octadecylpiperazin-1-yl)carbonyl]phenyl}methyl)-4,5-dihydro-1,2,4-oxadiazol-5-oneIC50800.0 [1]
Cacospongionolide EIC501400.0 [1], 96700.0 [2]
2-[(1-Benzyl-2-ethyl-3-oxamoyl-6,7,8,9-tetrahydrobenzo[g]indol-4-yl)oxy]acetic acidIC5011.0 [1], 17.0 [2]
2-[[3-(2-Amino-1,2-dioxoethyl)-1-cyclohexylmethyl-2-methyl-1H-benz[g]indol-4-yl]oxy]acetic acidIC504.0 [1], 11.0 [2]
2-[(1-Benzyl-2-methyl-3-oxamoyl-6,7,8,9-tetrahydrobenzo[g]indol-4-yl)oxy]acetic acidIC5010.0 [1], 16.0 [2]
2-[(1-Benzyl-2-ethyl-3-oxamoyl-7,8-dihydro-6H-cyclopenta[g]indol-4-yl)oxy]acetic acidIC507.0 [1], 13.0 [2]
2-[1-[(2-Benzylphenyl)methyl]-2-ethyl-3-oxamoylindol-4-yl]oxyacetic acidIC504.0 [1]
2-(2-Methyl-1-octyl-3-oxamoylindol-4-yl)oxyacetic acidIC508.0 [1], 18.0 [2]
(2S)-2-(1-Benzyl-2-methyl-3-oxamoylindol-4-yl)oxypropanoic acidIC50136.0 [1], 188.0 [2]
2-(1-Benzyl-2-ethyl-3-oxamoylindol-4-yl)oxy-4-phenylbutanoic acidIC5026.0 [1], 46.0 [2]
2-(1-Benzoyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acidIC5039.0 [1], 81.0 [2]
(2R)-2-(1-Benzyl-2-methyl-3-oxamoylindol-4-yl)oxypropanoic acidIC506.0 [1], 11.0 [2]
2-(1-Benzyl-2-ethyl-3-oxamoylindol-4-yl)sulfanylacetic acidIC50145.0 [1], 210.0 [2]
2-[1-[(2-Chlorophenyl)methyl]-2-methyl-3-oxamoylindol-4-yl]oxyacetic acidIC509.0 [1], 25.0 [2]
2-(1-Benzyl-2-ethyl-3-oxamoylindol-4-yl)oxy-2-methylpropanoic acidIC5025.0 [1], 29.0 [2]
2-[2-Methyl-1-[(2-methylphenyl)methyl]-3-oxamoylindol-4-yl]oxyacetic acidIC5015.0 [1], 45.0 [2]
2-[4-[2-(Benzenesulfonamido)-2-oxoethoxy]-1-benzyl-2-methyl-6,7,8,9-tetrahydrobenzo[g]indol-3-yl]-2-oxoacetamideIC503.0 [1], 7.0 [2]
3-[4-(3-Phenylmethoxy-2-tetradecoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-oneIC5014800.0 [1], 100000.0 [2]
3-[4-(3-Decoxy-2-tetradecoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-oneIC50280.0 [1], 1000.0 [2]
3-[4-[3-(4-Phenylbutoxy)-2-tetradecoxypropoxy]phenyl]-4H-1,2,4-oxadiazol-5-oneIC50290.0 [1], 26000.0 [2]
3-[4-(3-Benzhydryloxy-2-tetradecoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-oneIC50280.0 [1], 5000.0 [2]
3-[4-(2-Tetradecoxy-3-trityloxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-oneIC50900.0 [1], 2000.0 [2]
4-[[3-[4-[(5-Oxo-4H-1,2,4-oxadiazol-3-yl)methyl]phenoxy]-2-tetradecoxypropoxy]methyl]benzonitrileIC501100.0 [1], 7600.0 [2]
4-[[2-Octadecoxy-3-[4-[(5-oxo-4H-1,2,4-oxadiazol-3-yl)methyl]phenoxy]propoxy]methyl]benzonitrileIC50150.0 [1], 1150.0 [2]
CacospongionolideIC503000.0 [1], 90700.0 [2]
2-(1-Benzyl-2-ethyl-6-methyl-3-oxamoylindol-4-yl)acetic acidIC508.0 [1]
2-[[3-(2-Amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]propanoic acidIC509.0 [1], 10.0 [2]
[[3-(2-Amino-1,2-dioxoethyl)1-[(3-chlorophenyl)methyl]-2-ethyl-1H-indol-4-yl]oxy]acetic acidIC507.0 [1], 25.0 [2]
2-[2-Cyclopropyl-3-oxamoyl-1-[(2-phenylphenyl)methyl]indol-4-yl]oxyacetic acidIC506.0 [1], 23.0 [2]
[[3-(2-Amino-1,2-dioxoethyl)-1-[(4-fluorophenyl)methyl]-2-methyl-1H-indol-4-yl]oxy]acetic acidIC5030.0 [1], 74.0 [2]
[[3-(2-Amino-1,2-dioxoethyl)-1-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-1H-indol-4-yl]oxy]acetic acidIC5043.0 [1], 150.0 [2]
2-[2-Methyl-1-(naphthalen-1-ylmethyl)-3-oxamoyl-indol-4-yl]oxyethanoic acidIC509.0 [1], 17.0 [2]
[[3-(2-Amino-1,2-dioxoethyl)1-[(2,6-dichlorophenyl)methyl]-2-methyl-1H-indol-4-yl]oxy]acetic acidIC506.0 [1], 22.0 [2]
[[3-(2-Amino-1,2-dioxoethyl)-2-cyclopropyl-1-(phenylmethyl)-1H-indol-4-yl]oxy)acetic acidIC5028.0 [1], 41.0 [2]
((3-(2-Amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2-methyl-1H-indol-4-yl)oxy)acetic acidIC508.0 [1], 9.0 [2]
[[3-(2-Amino-1,2-dioxoethyl)-1-([1,1'-biphenyl]-2-ylmethyl)-2-ethyl-1H-indol-4-yl]oxy]acetic acidIC506.0 [1]
QuinacrineIC5076000000.0 [1]
UbenimexIC50100000.0 [1]
ZileutonIC501000000.0 [1]
PhenidoneIC501000000.0 [1]
AmentoflavoneIC5023800.0 [1]
ScalaradialIC5015.0 [1]
IndoxamIC5060.0 [1]
BolinaquinoneIC50200.0 [1]
OchnaflavoneIC503500.0 [1]
4-(s)-[(1-Oxo-7-phenylheptyl)amino]-5-[4-(phenylmethyl)phenylthio]pentanoic acidIC5021.0 [1]
N,N-Diethylhexadecane-1,2-diamineIC505600.0 [1]
4',7-FlavandiolIC503300.0 [1]
2-(Ethylamino)-1-hexadecanolIC503700.0 [1]
DysidineIC502000.0 [1]
N-Hexadecanoyl-leucineIC501660.0 [1]
7-BenzyloxytryptamineIC5052500.0 [1]
3-[(1E,3Z,5E,7E)-1-Carboxy-2,6-dimethyl-8-(2,6,6-trimethylcyclohexen-1-yl)octa-1,3,5,7-tetraen-3-yl]benzoic acidIC5040000.0 [1]
6-(4-Oxo-2-phenyl-chromen-6-yl)-2-phenyl-chromen-4-oneIC5069300.0 [1]
DidodecanoylphloroglucinolIC501600.0 [1]
2-(1-Benzyl-6-methoxy-2-methyl-1H-indol-3-yl)-2-hydroxy-acetamideIC50120900.0 [1]
2-(4-Phenoxyphenoxy)ethanamineIC507300.0 [1]
2-{4-[4-(4-Oxo-4H-chromen-2-yl)phenyl]phenyl}-4H-chromen-4-oneIC503000.0 [1]
N-(Carboxymethyl)-N-(3,5-bis(decyloxy)-phenyl)glycineIC50230.0 [1]
6-[3-(4-Oxo-4H-chromen-2-yl)-phenyl]-2-phenyl-chromen-4-oneIC5019900.0 [1]
5-Benzyloxytryptamine hydrochlorideIC5052000.0 [1]
2-{4-[3-(4-Oxo-4H-chromen-2-yl)phenyl]phenyl}-4H-chromen-4-oneIC5015500.0 [1]
6-[4-(4-Oxo-4H-chromen-2-yl)-phenyl]-2-phenyl-chromen-4-oneIC5063900.0 [1]
3-(4-(4-Oxo-4H-chromen-2-yl)phenyl)-2-phenyl-4H-chromen-4-oneIC5023200.0 [1]
(S)-4-Methyl-2-(2-oxohexadecanamido)pentanoic acidIC50300.0 [1]
Methyl 6-methoxy-2-(2-phenylethyl)quinoline-4-carboxylateIC501500.0 [1]
2-[2-Ethyl-3-oxamoyl-1-(phenylmethyl)benzo[g]indol-4-yl]oxyacetic acidIC5040.0 [1]
1-[2-(2-Methyl-4-carboxyphenoxy)ethyl]-3-dodecanoyl-1H-indole-2-carboxylic acidIC50570.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Phospholipase A2 group IIA Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Nov2024https://www.aatbio.com/data-sets/phospholipase-a2-group-iia-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 21). Quest Database™ Phospholipase A2 group IIA Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/phospholipase-a2-group-iia-inhibitors-ic50-ki.
BibTeXEndNoteRefMan